Correlative study on the JAK-STAT/PSMβ3 signal transduction pathway in asthenozoospermia.

The aim of the present study was to investigate the possible mechanism of Janus kinase (JAK)-signal transduction and activator of transcription (STAT)/PSMβ3 signaling in the occurrence of asthenozoospermia. We examined seminal fluid samples from 30 cases of asthenozoospermia and 30 healthy controls. Sperm was collected using the Percoll density gradient centrifugation method. The expression of JAK, STAT and PSMβ3 mRNA was assessed by reverse-transcription quantitative PCR and the protein levels of p-JAK, p-STAT and PSMβ3 were measured by western blot analysis. The PSMβ3 mRNA and protein expression levels were also measured after application of a JAK inhibitor, AG-490, to the control group, with a FITC-labeled monoclonal rabbit anti-human PSMβ3 primary antibody. The cells were observed under a laser confocal microscope. The mRNA levels of JAK, STAT and PSMβ3 in asthenozoospermia were decreased significantly (P<0.05). The protein levels of p-JAK, p-STAT and PSMβ3 in asthenozoospermia were also reduced and the differences were statistically significant (P<0.05). The PSMβ3 mRNA and protein expression levels were decreased in the control group after treatment with the JAK inhibitor, and levels were approximately equal to those of the asthenozoospermia group. PSMβ3 was mainly expressed in round-headed sperm, and less in asthenozoospermia. In conclusion, the JAK-STAT/PSMβ3 signaling transduction pathway may be involved in the pathogenic mechanism of asthenozoospermia.

Introduction

Statistically, male sterility accounts for 40–50% of total infertility. Low sperm motility and asthenozoospermia, account for up to 30–50% of male sterility (1). Analysis of differential proteins by sperm dimensional electrophoresis found that GP130 and Proteasomeβ3 (PSMβ3) were expressed abnormally (2). PSMβ3, also known as plasma membrane calcium (Ca2+) ATPase (PMCA3), is an important enzyme for Ca2+ transport in and out of cells (3). Ca2+ plays an important role in a series of processes, including sperm maturation, capacitation and sperm-egg binding (4). The PMCA3 gene, located on the X chromosome, is thought to be associated with sperm motility (5). Research on GP130 found that the Janus kinase (JAK)-signal transduction and activator of transcription (STAT) and RAS-MAPK signaling pathways play vital roles in the pathogenic mechanism of asthenozoospermia (6). The present study examined the possible mechanism of JAK-STAT/PSMβ3 signal transduction pathways in asthenozoospermia, providing new theoretical bases and therapeutic targets for clinical study.

Materials and methods

Patients

Thirty cases of male sterility, diagnosed with asthenozoospermia at the General Hospital of Beijing Military Region (Beijing, China) from June 2015 to January 2016, were selected. After 3–5 days of abstinence, 3 ml semen samples obtained by masturbation were analyzed by a sperm quality analyzer, BD-8000G (Xuzhou City Beidou Technology & Trading Co., Ltd., Xuzhou, China). With reference to World Health Organization (WHO) standards on the diagnostic criteria of asthenozoospermia, the percentage of forward moving sperm (grade A + B) was <50% or grade A sperm movement was <25%. The age range of patients was 21–33 years, with an average age of 26.4±5.5 years. At the same time, 30 healthy controls with normal semen samples, according to physical exam were chosen, aged 20–34 years, with an average age of 26.2±5.3 years. The age difference between the two groups was not statistically significant (P>0.05).

The present study was approved by the Ethics Committee of the General Hospital of Beijing Military Region and we received informed consent from all participating patients.

Percoll density gradient centrifugation for sperm collection

One and a half milliliters of 90% and 1.5 ml of 45% Percoll solutions were added to 15 ml centrifuge tubes (90% below, 45% above). Subsequently, 3 ml of semen was added. After centrifugation (200 × g for 20 min), the supernatant was removed and sperm sediment at the bottom was washed with IVF-20 culture medium twice. The sperm precipitate was collected for later use.

Detection of JAK, STAT and PSMβ3 mRNA by reverse transcriptase quantitative polymerase chain reaction (RT-qPCR)

Total RNA was extracted using RNA Pure, a high purity, total RNA, rapid extraction TRIzol reagent (Sigma-Aldrich, St. Louis, MO, USA), and cDNA was synthesized after assessing the purity and concentration of RNA. The primer concentrations were 10 pmol/µl. Primers were designed using Primer Premier 5.0 and were produced by Sangon Biotech Co. Ltd. (Shanghai, China). Primer sequences used were: JAK forward, 5′-TGCTGTCCAGACAAGAATGC-3′ and reverse, 5′-TTCTGCAACCGTCTCTTCCT-3′; STAT forward, 5′-TAACGAGGAGCTGGTGGAGT-3′ and reverse, 5′-GCTTGCGTGTCAGAAAAGTT-3′; PSMβ3 forward, 5′-GAAATCGCAGCCATAGTATC-3′ and reverse, 5′-CTGATGACGGTGAACTTCTG-3′; and β-actin forward, 5′-ATGTTTGAGACCTTCAACAC-3′ and reverse, 5′-GGCCATCTCTTGCTCGAAGTC-3′. According to the Applied Biosystems StepOne system, the reaction mixture contained 10 µl of 2X Smart Green PCR mix, 0.2 µl of each 10 pmol/µl primer, 1 µl of cDNA template, and 8.6 µl of ddH2O for a total volume of 20 µl. The thermal profile was 40 cycles of pre-denaturation at 95°C for 10 min, denaturation at 94°C for 15 sec, 60°C for 1 min and extension at 72°C for 30 sec. The 2−∆∆Cq relative quantitative method was used to show the relative expression levels of each target gene.

Measurement of p-JAK, p-STAT and PSMβ3 by western blot analysis

Each well of the plate was treated by 200 µl lysis buffer and maintained in an ice bath for 1 h. Sample solutions were then centrifuged for 15 min at 4°C. Protein concentration of the centrifuged supernatant was determined by Coomassie Brilliant Blue staining, and preserved at −80°C. Total protein (50 µg) from each sample was separated by electrophoresis. The samples were then transferred to PVDF membranes (90 V, 1.5 h at low temperature). Rabbit anti-human p-JAK (dilution: 1:500; cat. no.: ab138005), rabbit monoclonal p-STAT (dilution: 1:500; cat no.: ab32143) and mouse monoclonal PSMβ3 (dilution: 1:500; cat no.: ab128094), purchased from Abcam (Cambridge, MA, USA), were added after blocking and incubated at 4°C overnight, following four washes with phosphate-buffered saline (PBS). Horseradish peroxidase-conjugated goat anti-rabbit IgG (dilution: 1/2000; Abcam; cat no.: ab6721) was added to membranes and incubated at 4°C overnight. After three washes with PBS, the ECL enhanced chemiluminescence reagent kit was used for signal development. After thorough scanning of negative film, a semi-quantitative analysis was carried out on the bands by Shanghai Tianneng gel imaging processing system software. Data were normalized to levels of β-actin.

JAK inhibitor intervention

Cases without asthenozoospermia were randomly divided into the non-treated control group (n=15) and JAK inhibitor-treated group (n=15). The levels of PSMβ3 mRNA and protein were measured after application of the JAK inhibitor, AG-490. Immunofluorescent staining of PSMβ3 was observed by a laser confocal microscope. The cells were stained as follows: 25-min incubation with 0.25% H2O2, 15 min with 0.3% Triton X-100, three washes with PBS for 5 min, and 30-min incubation with 10% normal goat serum. Rabbit anti-human PSMβ3 monoclonal antibody (1:200) was then added and allowed to incubate at 4°C overnight. The samples were washed three times for 5 min, and biotin-labeled goat anti-rabbit IgG (1:100) was added and left to incubate at room temperature for 30 min. Three 5 min washes with PBS were performed again, and streptavidin-biotin complex-fluorescein isothiocyanate (SABC-FITC)-labeled secondary antibody (1:100) was added, and incubated at room temperature for 30 min. Next, we performed three washes with PBS for 5 min. The samples were stained with DAPI for 5 min, washed in PBS, and mounted using antifade mounting solution. Staining was observed under a confocal microscope (Nikon, Tokyo, Japan). For the blank control group, PBS was used instead of PSMβ3 antibody as described above.

Statistical analysis

Data were analyzed using SPSS 19.0 statistical software (Chicago, IL, USA), and quantitative data are presented as mean ± standard deviation. Comparisons between groups were analyzed by one-way ANOVA, and pairwise comparisons were analyzed using LSD or Bonferroni test. Differences were considered to indicate a statistically significant difference when P<0.05.

Results

Comparison of mRNA expression levels

The mRNA levels of JAK, STAT and PSMβ3 in asthenozoospermia were significantly lower than in the control group (P<0.05), and the levels of PSMβ3 mRNA in the JAK inhibitor group were significantly downregulated when compared with the control non-treated group (P<0.05), which were approximately equal to the asthenozoospermia group (P>0.05) (Fig. 1).

Figure 1.

Expression of JAK, STAT, and PSMβ3 mRNA in the different groups. (A) PCR was performed to detect JAK, STAT and PSMβ3 mRNA. (B) Quantification of PCR data in A. JAK, Janus kinase; STAT, signal transduction and activator of transcription; PCR, polymerase chain reaction.

Comparison of protein expression levels

The protein levels of JAK, STAT and PSMβ3 in asthenozoospermia were significantly lower than the control group (P<0.05), and the levels of PSMβ3 protein in the JAK inhibitor intervention group were significantly lower when compared with the control non-treated-group (P<0.05), which were approximately equal to the asthenozoospermia group (P> 0.05) (Fig. 2).

Figure 2.

Expression of JAK, STAT and PSMβ3 protein in the different groups. (A) Western blot analysis was performed to detect the protein levels of JAK, STAT and PSMβ3. (B) Quantification of western blot analysis data in A. JAK, Janus kinase; STAT, signal transduction and activator of transcription.

Immunofluorescent staining of PSMβ3

PSMβ3 was mainly expressed in round-headed sperm, and less expressed in asthenozoospermia (Fig. 3).

Figure 3.

Immunofluorescent staining of PSMβ3. (A) Asthenozoospermia group (PSMβ3 is shown in red). (B) Control group.

Discussion

JAKs are a family of protein tyrosine kinases that are involved in cell signaling downstream of cytokine receptors, which can activate signal transduction and activator of transcription (STAT) proteins. A previous study reported that the JAK-STAT pathway was one of the most common signaling pathways in vivo (7). JAK-STAT signaling is involved in cell proliferation, differentiation, survival, apoptosis, mediating immune disorders and tumor formation. Wawersik et al found that the JAK-STAT pathway participates in the process of male germ cell proliferation and differentiation (8). Issigonis et al reported that the JAK-STAT pathway functions in maintaining the microenvironment necessary for germ cells to survive (9).

Previous studies have confirmed that the membrane voltage-dependent Ca2+ channels are involved in the capacitation of sperm and the acrosome reaction (10). In addition, the Ca2+-dependent regulation of sperm motility is mainly mediated by related Ca2+ channels on the sperm cell membrane. Ca2+ channels are transmembrane protein complexes, generally composed of four subunits: α1, α2/δ, β and γ. The most important subunit is α1, which is the infiltration pathway component of all voltage-gated Ca2+ channels and is also the binding site of voltage-sensitive, channel-specific drugs and toxins (11). Mutations in the α1 subunit can lead to reduced sperm motility, causing asthenozoospermia and resulting in male infertility (12). Other studies found that sperm cation channel (CatSper) family proteins were specifically expressed on sperm cell membranes, and played an important role in the regulation of sperm hyperactivation (13). CatSper channels are known Ca2+ channels that are expressed in spermatogenic cells and mature sperm. CatSper1 and CatSper2 are considered to be necessary for mouse sperm motility and fertility, and their absence can result in infertility (14). There are two main modes for Ca2+ transport out of cells: Sodium-Ca2+ exchangers (NCX) and PMCAs. PMCAs have a high affinity for Ca2+, but small capacity. PMCAs are mainly responsible for the fine control of Ca2+ transport and play an important role in cell signal transduction (15). PMCAs belongs to the p-type ATPase family and can form a high-energy phosphorylated intermediate in the reaction cycle. Phosphorylated PMCAs exist in two conformational states, E1 and E2, each being alternative for the other (16). PMCAs in mammals are encoded by four genes that encode PMCA1-4, and are located on human chromosomes 12, 3, 1 and X. The most important method of regulating PMCA activity is interaction with calmodulin (17). The combination of calmodulin and PMCA depends on Ca2+. When Ca2+ is lower than the Km value needed for the combination of PMCA and calmodulin, PMCA remains inactivated by calmodulin. Only when Ca2+ is higher than the Km value, can the two bind with each other in a Ca2+-dependent manner. PMCAs play an important role in regulating the spatial and temporal dynamic distribution of intracellular Ca2+. Furthermore, they participate in multiple signaling pathways related to intracellular Ca2+. The interaction between PMCAs and other PDZ domain-containing proteins is one of the ways by which PMCAs participate in signal transduction (18).

Research subjects in most related studies are animals such as mice; thus, it remains to be further analyzed whether sperm vitality, Ca2+ distribution, Ca2+ channel status and Ca2+-dependent regulation of PMCAs apply to humans (19). The present study demonstrates that the levels of JAK, STAT and PSMβ3 mRNA in asthenozoospermia were decreased significantly, and the levels of p-JAK, p-STAT and PSMβ3 protein in asthenozoospermia were also reduced. The differences were statistically significant. The mRNA and protein levels of PSMβ3 were decreased after the application of a JAK inhibitor in the control group, and were approximately equal to the asthenozoospermia group. PSMβ3 was mainly expressed in round-headed sperm, and less expressed in asthenozoospermia. This finding suggests that the JAK-STAT/PSMβ3 signal transduction pathway may be involved in the pathogenic mechanism of asthenozoospermia. Specifically how the JAK-STAT pathway regulates the expression of PSMβ3 requires further exploration.